Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03499353
Brief Title: Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

First Submitted : April 9, 2018
First Submitted that Met QC Criteria : April 9, 2018
First Posted : April 17, 2018

Last Update Submitted that Met QC Criteria : March 22, 2021
Last Update Posted : March 24, 2021